)
GeneDx (WGS) investor relations material
GeneDx Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of Katherine Stueland as director is up for shareholder vote, with board recommending approval.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026 is proposed.
Advisory vote on executive compensation for named executive officers is included.
Advisory vote on the frequency of future say-on-pay votes (every 1, 2, or 3 years) is presented.
Other business may be addressed as appropriate during the meeting or any adjournment.
Board of directors and corporate governance
Katherine Stueland is nominated for election to the board.
Executive compensation and say-on-pay
Shareholders will vote on a non-binding advisory basis to approve compensation for named executive officers.
Shareholders will indicate preferred frequency for future advisory votes on executive compensation.
- Annual meeting to vote on director, auditor, executive pay, and say-on-pay frequency, with board support.WGS
Proxy filing30 Apr 2026 - 2026 guidance targets $540M–$555M revenue, 33%–35% test growth, and 71% gross margin.WGS
Q4 202511 Apr 2026 - Expanding genetic testing into new pediatric and prenatal markets with tailored sales and support.WGS
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Expanding genetic testing access and automation drives growth and profitability in rare disease care.WGS
Jefferies Global Healthcare Conference 20253 Feb 2026 - Q2 revenue up 52% YoY, gross margin at 62%, FY guidance raised, profitability expected 2025.WGS
Q2 20242 Feb 2026 - Epic integration and exome focus drive growth, margins, and data opportunities in rare disease.WGS
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Transformation to exome/genome focus drives margin growth and sets up profitability for 2025.WGS
Jefferies Global Healthcare Conference31 Jan 2026 - Rapid growth in exome testing, margin expansion, and data leadership drive market dominance.WGS
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 2024 saw record revenue, first adjusted profit, and raised guidance amid exome/genome growth.WGS
Q3 202418 Jan 2026
Next GeneDx earnings date
Next GeneDx earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)